Yilong CUI

Dr. Yilong CUI


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2014 in Neuroscience Bulletin
Verified
Journal Article
Closed access
PDF file
YCYilong CUI
Yilong CUI
YKYosky Kataoka
Yosky Kataoka
YWYasuyoshi Watanabe
Yasuyoshi Watanabe

16 October 2009 in Journal of Nuclear Medicine
Verified
Journal Article
Open access
PDF file
YCYilong CUI
Yilong CUI
TTTadayuki Takashima
Tadayuki Takashima
MTMisato Takashima-Hirano
Misato Takashima-Hirano
YWYasuhiro Wada
Yasuhiro Wada
MSMiho Shukuri
Miho Shukuri
YWYasuyoshi Watanabe
Yasuyoshi Watanabe
Neurogenic inflammation triggered by extravasation of plasma protein has been hypothesized as a key factor in the generation of the pain sensation associated with migraine. The principal immune cell that responds to this inflammation is the parenchymal microglia of the central nervous system. Methods: Using a PET technique with 11C-(R)-[1-(2-chlorophenyl)-N-methyl-N-(1-methyl-propyl)-3-isoquinolinecarboxamide] (11C-PK11195), a PET ligand for peripheral type–benzodiazepine receptor, we evaluated the microglial activation in the rat brain after generation of unilateral cortical spreading depression, a stimulation used to bring up an experimental animal model of migraine. Results: We found a significant increase in the brain uptake of 11C-PK11195, which was completely displaceable by the excess amounts of unlabeled ligands, in the ipsilateral hemisphere of the spreading depression–generated rats. Moreover, the binding potential of 11C-PK11195 in the spreading depression–generated rats was significantly higher than that in the sham-operated control rats. Conclusion: These results suggest that as an inflammatory reaction, microglial cells are activated in response to the nociceptive stimuli induced by cortical spreading depression in the rat brain. Therefore, the 11C-PK11195 PET technique could have a potential for diagnostic and therapeutic monitoring of neurologic disorders related to neuroinflammation such as migraine.

1 September 2018 in NeuroImage
Verified
Journal Article
Closed access
YZYing Zeng
Ying Zeng
DHDi Hu
Di Hu
WYWei Yang
Wei Yang
EHEmi Hayashinaka
Emi Hayashinaka
YWYasuhiro Wada
Yasuhiro Wada
YCYilong CUI
Yilong CUI

1 March 2015 in NeuroImage
Verified
Journal Article
Closed access
YCYilong CUI
Yilong CUI
HTHiroshi Toyoda
Hiroshi Toyoda
TSTakeo Sako
Takeo Sako
KOKayo Onoe
Kayo Onoe
EHEmi Hayashinaka
Emi Hayashinaka
YWYasuyoshi Watanabe
Yasuyoshi Watanabe

2 March 2024 in Antioxidants
Verified
Journal Article
Open access
PDF file
DHDi Hu
Di Hu
SKshigeru kabayama
shigeru kabayama
Yasuyoshi WatanabeYasuyoshi Watanabe
Yasuyoshi Watanabe
YCYilong CUI
Yilong CUI
Molecular hydrogen, the smallest and lightest molecule, serves as an intense reducing agent. Its distinct characteristics, including minimal size and neutral charge, enhance bioavailability and facilitate significant biological effects. Previously considered physiologically inert, hydrogen has gained recognition as a powerful therapeutic agent, known for its antioxidative and anti-inflammatory properties. Electrolyzed hydrogen water (EHW), enriched with molecular hydrogen, demonstrates remarkable antioxidative capabilities, indicating potential benefits for various diseases. Inflammation-induced reactive oxygen species (ROS) amplify inflammation, leading to secondary oxidative stress and creating a crosstalk between ROS and inflammatory responses. This crosstalk contributes to the pathogenesis and progression of chronic diseases. EHW interrupts this crosstalk, reducing inflammatory cytokines and oxidative stress across various disease models, suggesting therapeutic potential. EHW is also known for its anti-inflammatory effects, extending to pain management, as evidenced in models like sciatic nerve ligation and inflammatory pain. In an inflammatory bowel disease (IBD) model, EHW effectively alleviates abdominal pain, mitigating 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced inflammation and oxidative stress, offering insights for clinical applications. Additionally, hydrogen selectively targets harmful radicals, and EHW intake helps balance stress-induced hormonal dysregulation, potentially easing disorders associated with chronic stress.

4 March 2013 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
PDF file
YCYilong CUI
Yilong CUI
QLQing‐Hua Li
Qing‐Hua Li
HYHisao Yamada
Hisao Yamada
YWYasuyoshi Watanabe
Yasuyoshi Watanabe
YKYosky Kataoka
Yosky Kataoka